课题基金 / 基金详情

Novel FMDV Vaccine Technology for Africa

Novel FMDV Vaccine Technology for Africa
非洲口蹄疫新疫苗技术
批准号:
105652
负责人:
金额:
$56.2万
依托单位:
依托单位国家:
英国
项目类别:
BEIS-Funded Programmes
财政年份:
2019
资助国家:
英国
项目状态:
已结题
起止时间:
2019 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
口蹄疫病毒(FMDV)在大多数非洲国家流行。口蹄疫是一种感染牲畜的高度传染性和潜在致命性疾病。该病对非洲造成巨大的经济影响,因为它降低了农民的生产力及其出口农产品的能力,保守估计损失为8亿美元。口蹄疫病毒有不同的血清型,每种血清型都需要自己的疫苗来保护动物。每种血清型都被分成不同的毒株,这些毒株可以进化,因此它们也需要一种新的疫苗来预防它们。不同的血清型和毒株在非洲的不同区域有所不同,因此每个区域都需要自己的疫苗范围。撒哈拉以南非洲地区有口蹄疫疫苗,但它们目前不适合用于目的,因为:1)它们太昂贵;2)在许多非洲地区,它们不能防止流行毒株;3)它们必须反复接种;4)它们必须在不间断的冷链中冷藏,这对许多牲畜饲养者来说是不可能的。该项目将研究生产新的FMDV疫苗的可行性,这种疫苗比非洲目前的疫苗更便宜、生产更简单、更稳定、与流行毒株相匹配并且具有更好的区域覆盖率
英文摘要
Foot and Mouth disease virus (FMDV) is endemic in most African countries. FMD is a highly infectious and potentially fatal disease that infects livestock. The disease has a huge economic impact in Africa, as it reduces the productivity of farmers and their ability to export produce, with losses conservatively estimated at USD 800 million. There are different serotypes of FMDV, and each requires its own vaccine in order to protect animals. Each serotype is separated into different strains and these can evolve so that they too require a new vaccine to protect against them. The different serotypes and strains vary in different regions in Africa, so that each region requires its own range of vaccines. There are vaccines available for FMD in sub-Saharan Africa but they are not currently fit for purpose because: 1) they are too expensive, 2) in many African regions they do not protect against the circulating strains 3) they must be given repeatedly and 4) they must be kept refrigerated in an uninterrupted cold chain , which is not possible for many livestock keepers. The project will study the feasibility of producing new FMDV vaccines that are cheaper, simpler to produce, more stable, match circulating strains and have better regional coverage than the current vaccines in Africa
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
FMDV 3D蛋白与MAVS、TRIM25分别互作抑制RLR信号通路的作用及机制
  • 批准号:
    32373094
  • 项目类别:
    面上项目
  • 资助金额:
    50万元
  • 批准年份:
    2023
  • 负责人:
    齐静
  • 依托单位:
猪树突状细胞XCR1靶向提呈促进FMDV免疫应答的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2023
  • 负责人:
  • 依托单位:
猪树突状细胞CD205纳米抗体介导FMDV抗原靶向提呈及其效应机制
  • 批准号:
    32102690
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    程海卫
  • 依托单位:
DExD/H-box RNA解旋酶介导FMDV-IRES依赖性翻译和复制及其在抗病毒免疫中的作用机制